DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

GPT Healthcare Limited — Board Meeting Intimation

NSE 2 hrs ago·25 Jul 2026, 8:31 am

GPT Healthcare

GPT Healthcare has announced that its board will meet on August 3, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026. This is a routine corporate procedure where the board evaluates the company's performance before the figures are officially released to the public.

For investors, this update is a key milestone as it provides the first official look at GPT Healthcare's financial health and operational progress for the period. The results will likely reveal the company's revenue growth, profitability, and any strategic shifts, which are critical factors for assessing the stock's current trajectory.

Investors should watch for the official release of these results to understand the company's performance against market expectations. Any significant deviation from forecasts or commentary on future growth plans could influence the stock's movement in the coming days.